What are the benefits of targeting lower BP levels in patients with micro- or macroalbuminuria?
Patients with micro- or macroalbuminuria are at increased risk of both progressive kidney disease and cardiovascular events. Targeting lower BP levels has been shown to reduce the rate of urinary albumin excretion, which is associated with a better kidney and cardiovascular prognosis. However, stronger evidence is needed before it can be concluded that treatment to reduce the rate of urinary albumin excretion will improve prognosis.